Stock Information
Inhibrx Biosciences Inc (INBX)
Ticker Symbol: INBX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $923.96 mil
Piotroski score: 1
PE Ratio: N/A
EPS (TTM): -6.2439
Revenue (TTM): $0.08 M
Dividend Yield: N/A%
ROE: -255.98%
Latest News
-
Why Inhibrx Biosciences (INBX) Is Up 46.3% After New Ozekibart Colorectal Cancer Data And FDA Plans
Sun, Apr 26, 2026 11:05 PM
-
Inhibrx Biosciences Highlights 20% ORR for Ozekibart Combo in Late-Line Colorectal Cancer
Sat, Apr 25, 2026 11:12 AM
Key Financials
Financial data not available